// App-Quantinova.ai

2367 : cGMP production of a chimeric virus-like particle vaccine for prevention of HPV-associated cancers

Researchers

Presenter

  • George W. Buchman

Principal Investigators

  • Brian P. Howard

  • Nadia Abdallah

  • Bala Medicherla

  • Mary Anne Fisher

  • Jonathan M. White

  • Michelle L. Kennedy

  • Shizuko Sei

  • Richard B.S. Roden

  • Christina Schellenbacher

  • Reinhard Kirnbauer

  • Robert H. Shoemaker

Medical Centers

  • Paragon Bioservices, Baltimore, MD

  • MRIGlobal, Kansas City, MO.

  • Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.

  • Johns Hopkins University, Baltimore, MD

  • Medical University of Vienna, Vienna, Austria

Locations

  • United States

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Human papillomavirus 16

Drug/Treatment

  • Human papilloma virus vaccine

Outcome

  • N/A

Study Design

  • First-In-Human

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved